BCG Vaccine News and Research

RSS
The BCG Vaccine is a vaccine containing bacillus Calmette-Guerin (BCG), an attenuated strain of Mycobacterium bovis, with non-specific immunoadjuvant and immunotherapeutic activities. Although the mechanism of its anti-tumor activity is unclear, immunization with BCG vaccine likely activates a Th1 cytokine response that includes the induction of interferon. Vaccination with BCG vaccine may be immunoprotective against infection with Mycobacterium tuberculosis.
BuruliVac project getting closer to a vaccine

BuruliVac project getting closer to a vaccine

Emergent receives NIAID grant to advance development of MVA85A TB vaccine

Emergent receives NIAID grant to advance development of MVA85A TB vaccine

Bill Gates meets MTBVAC TB vaccine researchers in Spain

Bill Gates meets MTBVAC TB vaccine researchers in Spain

Study shows decline in number of TB cases across America during 2009

Study shows decline in number of TB cases across America during 2009

Einstein researchers develop tuberculosis vaccine candidate

Einstein researchers develop tuberculosis vaccine candidate

BCG vaccine can help immune system recognise cancer cells as 'foreign'

BCG vaccine can help immune system recognise cancer cells as 'foreign'

Aeras, OETC announce initiation of new TB vaccine Phase IIb trial in patients with HIV

Aeras, OETC announce initiation of new TB vaccine Phase IIb trial in patients with HIV

New findings from STELARA psoriasis clinical trial to be presented at 22nd World Congress of Dermatology

New findings from STELARA psoriasis clinical trial to be presented at 22nd World Congress of Dermatology

McGill research team finds distinct disease-causing mutations and saves baby girl

McGill research team finds distinct disease-causing mutations and saves baby girl

Financial Times, other media outlets highlight key issues in Global TB fight

Financial Times, other media outlets highlight key issues in Global TB fight

WHO report urges countries to step up fight against drug-resistant TB

WHO report urges countries to step up fight against drug-resistant TB

Researchers launch free online Atlas of TB vaccination policies around the world

Researchers launch free online Atlas of TB vaccination policies around the world

Researchers identify protein that triggers immune response in TB-infected people

Researchers identify protein that triggers immune response in TB-infected people

MEPs, OETC visit new TB vaccine trial site to express support for candidate development

MEPs, OETC visit new TB vaccine trial site to express support for candidate development

New tuberculosis vaccine provides better protection

New tuberculosis vaccine provides better protection

Research: Environmental bacteria compromises effectiveness of BCG vaccine

Research: Environmental bacteria compromises effectiveness of BCG vaccine

Aeras Global receives FDA grant to develop biomarkers for TB vaccine

Aeras Global receives FDA grant to develop biomarkers for TB vaccine

Aeras Global TB Vaccine Foundation to initiate clinical trial of new investigational vaccine

Aeras Global TB Vaccine Foundation to initiate clinical trial of new investigational vaccine

Aeras and Crucell commence Phase II study of TB vaccine candidate in infants

Aeras and Crucell commence Phase II study of TB vaccine candidate in infants

Researchers identify mechanism to reduce pathogenic effect of bacillus bacteria

Researchers identify mechanism to reduce pathogenic effect of bacillus bacteria